[1] |
XUE Liqiong, GUO Ye, CHEN Libo.
Expert consensus on the management of adverse events in patients receiving targeted agents for advanced thyroid cancer (2023 edition)
[J]. China Oncology, 2023, 33(9): 879-888.
|
[2] |
YUAN Xinyue, YAO Yao, CHENG Shuai, ZHENG Xin, ZHANG Yuan.
Clinical study on high-risk factors for contralateral lymph node metastasis in unilateral papillary thyroid carcinoma
[J]. China Oncology, 2023, 33(6): 619-628.
|
[3] |
QU Ning, WANG Yuting, MA Ben, WANG Yu.
Advances in basic research, clinical diagnosis and treatment of thyroid cancer in 2022
[J]. China Oncology, 2023, 33(5): 423-430.
|
[4] |
TANG Duocai, ZHOU Shukui, ZHANG Guiyin, LIU Lei, LIAO Hong.
Analysis of risk factors of recurrence in non-muscle invasive bladder cancer patients after initial transurethral resection of bladder tumor
[J]. China Oncology, 2023, 33(5): 478-483.
|
[5] |
CHEN Zhujun, DING Zhimin, MA Xiaolu, WANG Yanchun, HU Haoyun, LU Renquan, GUO Lin.
Analysis of characteristics of infectious pathogens in malignant tumors combined with bloodstream infection and significance of serum glucose detection
[J]. China Oncology, 2023, 33(10): 927-935.
|
[6] |
CAO Mengxuan, HU Can, ZHANG Yanqiang, HUANG Ling, DU Yian, YU Pengcheng, ZHANG Ruolan, XU Zhiyuan, CHENG Xiangdong.
Analysis of risk factors of early recurrence and metastasis after radical resection of gastric cancer
[J]. China Oncology, 2022, 32(7): 588-595.
|
[7] |
SUN Di, SUN Yuqing, ZHANG Xin, HUANG Lisha, LIN Yansong.
The relationship between genetic characteristics and clinical characteristics and the efficacy of 131I therapy in children and adolescents with locally advanced or metastatic differentiated thyroid cancer
[J]. China Oncology, 2022, 32(5): 380-387.
|
[8] |
DENG Shuting, FENG Yuan, QIAN Kai, GUO Kai, WANG Zhuoying.
Meta-analysis of the association between gene alterations and distant metastasis of differentiated thyroid carcinoma in children and adolescents
[J]. China Oncology, 2022, 32(5): 388-396.
|
[9] |
LIU Jia, LI Guanghan, GAO Luying, ZHANG Zijie, WANG Ying, XIONG Ying, ZHANG Bo.
Establishment and test of graded diagnostic model of thyroid cancer in children and adolescents
[J]. China Oncology, 2022, 32(5): 397-403.
|
[10] |
GUO Wenting, MU Zhuanzhuan, LI Zheng, ZHANG Yingqiang, JIN Xiaona, LIN Yansong.
Clinical outcome of 131I therapy in differentiated thyroid cancer patients with suspicious high thyroglobulin concentration
[J]. China Oncology, 2022, 32(5): 410-416.
|
[11] |
MEI Xiaoran, FENG Fang, WANG Hui, WEI Zhixiao.
Analysis of therapeutic response of iodine positive metastasis lymph nodes in differentiated thyroid cancer after 131I treatment
[J]. China Oncology, 2022, 32(11): 1091-1097.
|
[12] |
SHEN Zan, SHAO Zhimin, Cancer Support Rehabilitation Therapy Group of Chinese Medical Association Oncology Branch, the Drafting Committee of China Breast Cancer Related Heart Disease Diagnosis and Treatment Consensus.
Chinese consensus of cardio-oncology in breast cancer
[J]. China Oncology, 2022, 32(10): 1016-1036.
|
[13] |
CHEN Guo , HAN Pengli , CHEN Keru , LI Mingchuang , ZHANG Qingsong , CHEN Zheng , DONG Hanhua , QIAN Yuejun , LÜ Jing .
Molecular mechanism of miR-19b-3p regulating apoptosis of medullary thyroid cancer cells by targeting MTUS1
[J]. China Oncology, 2021, 31(5): 390-396.
|
[14] |
YUAN Hao , JIANG Xiaofei , YOU Qinghua , ZHU Hongbo , YE Huiying , WU Wen , QIAN Fengyuan , ZHONG Ming , LI Yongping .
Clinical application of fine needle puncture Diff-Quik staining for the differentiation and protection of parathyroid glands in thyroid carcinoma surgery
[J]. China Oncology, 2021, 31(4): 302-307.
|
[15] |
WU Yuanyuan , WANG Jun , LIU Qinjiang , ZHANG Ming .
Analysis of prognostic factors and treatment strategies of anaplastic thyroid carcinoma
[J]. China Oncology, 2021, 31(3): 212-220.
|